74 related articles for article (PubMed ID: 879912)
1. Anti-arrhytmic and general pharmacological properties of some 1,3-benzodioxole derivatives.
Fregnan GB; Ferni G; Prada M
Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):286-301. PubMed ID: 879912
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic and hemodynamic effects of prifuroline.
Benharkate M; Plassard G; Legeai J; Worcel M
Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
4. [Anti-arrhythmia properties of pyromecaine].
Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic activity of the local anaesthetic fomocaine and some of its analogues.
Bräunig B; Busch AE; Mutschler E; Wess J; Oelschläger H
Arzneimittelforschung; 1989 Nov; 39(11):1436-9. PubMed ID: 2619777
[TBL] [Abstract][Full Text] [Related]
6. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
7. [Chemistry and biological properties of substituted 3-amino-1H-isoindoles (author's transl)].
May HJ; Kretzschmar R; Neumann W; Gries J
Arzneimittelforschung; 1980; 30(9):1487-93. PubMed ID: 7193014
[TBL] [Abstract][Full Text] [Related]
8. [Anti-arrhythmia properties of marcaine].
Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
[TBL] [Abstract][Full Text] [Related]
9. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
10. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
Lindner E; Kaiser J; Schacht U
Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
[TBL] [Abstract][Full Text] [Related]
11. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
13. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Bianchi C; Sanna GP; Turba C
Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
[No Abstract] [Full Text] [Related]
14. [Effects of 6,7-dimethoxycoumarin on experimental arrhythmia].
Du GY; Ye WH; Lü F; Jing HD
Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S16-8. PubMed ID: 8010065
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
[TBL] [Abstract][Full Text] [Related]
17. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters.
Ernest K
Pol J Pharmacol Pharm; 1975; 27(4):381-98. PubMed ID: 1166019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
